Neutral
GlobeNewsWire
yesterday
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases
